Breast Cancer | Tumor

FDA Grants Regular Approval to Trodelvy for Certain Patients With Triple-Negative Breast Cancer

April 7th 2021, 8:29pm


Approximately one year after granting Trodelvy accelerated approval, the Food and Drug Administration granted a regular approval to the antibody-drug conjugate in certain patients with pretreated triple-negative breast cancer.

Endocrine Therapies May Lower Estradiol Levels in Men With Breast Cancer

April 7th 2021, 6:00pm


Men with breast cancer who were treated with Soltamox plus gonadotropin-releasing hormone analogue had a decrease in estradiol levels of 85%, whereas Aromasin plus gonadotropin-releasing hormone analogue reduced these levels by 72%.

FDA Committee Votes to Delay Approval Decision on Keytruda in Early TNBC Until More Data is Available

April 4th 2021, 3:00pm


The Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted in favor of waiting for more data before making an approval decision involving the use of Keytruda in early triple-negative breast cancer.

Off Our Chests: An Oncologist Turned Caregiver and His Wife Share Their Cancer Journey From All Angles

April 1st 2021, 3:00pm


Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.

Keytruda May Not Improve Overall Survival Versus Chemotherapy in Metastatic Triple-Negative Breast Cancer

March 26th 2021, 6:00pm


Although Keytruda did not improve overall survival when compared with chemotherapy, patients with a higher PD-L1 expression may derive a greater benefit with Keytruda, as shown with a longer median overall survival.

Friday Frontline: Baltimore Restaurant Owner Drives Six Hours to Cook for Customer with Terminal Cancer, Breast Cancer Treatment Pioneer José Baselga Dies from Rare Degenerative Disorder, and More

March 26th 2021, 3:00pm


From a Baltimore restaurant owner traveling six hours to cook for a terminally ill customer to the death of a pioneer in breast cancer treatment, here’s what’s happening in the cancer landscape this week.

Younger Age and Non-White Race Associated With an Increased Likelihood of Filing for Bankruptcy After a Breast Cancer Diagnosis

March 23rd 2021, 6:00pm


Data from a recent study demonstrates that patients with breast cancer — especially those who are younger, privately insured, of non-White race and lower-income — are more likely to file for bankruptcy than those without cancer.

Is Delaying Cancer Screening Due to COVID-19 Fears Worth the Risk?

March 18th 2021, 6:00pm


Postponing tests or doctor visits during the pandemic may increase women’s risk of cancer.

Understanding Survivor’s Guilt

March 18th 2021, 4:00pm


Why do some survive cancer, while others don’t? And why do those who survive often feel the aches of survivor’s guilt? Here, a survivor shares how she learned to cope.

Diet and Exercise Can Play an Important Role in Breast Cancer Survivors

March 17th 2021, 1:00pm


Increasing healthy eating habits and exercise is important in patients with breast cancer, according to an expert from Mass General Cancer Center.